Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk.
View / Open Files
Authors
Giorgi Rossi, Paolo
Hélin, Valerie
Astley, Susan
Mantellini, Paola
Nitrosi, Andrea
Harkness, Elaine F
Gauthier, Emilien
Puliti, Donella
Balleyguier, Corinne
Baron, Camille
Gilbert, Fiona J
Grivegnée, André
Pattacini, Pierpaolo
Michiels, Stefan
Delaloge, Suzette
Publication Date
2021-10-06Journal Title
Scientific reports
ISSN
2045-2322
Volume
11
Issue
1
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Giorgi Rossi, P., Djuric, O., Hélin, V., Astley, S., Mantellini, P., Nitrosi, A., Harkness, E. F., et al. (2021). Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk.. Scientific reports, 11 (1) https://doi.org/10.1038/s41598-021-99433-3
Abstract
We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo-DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists' visual assessment. Pooled analysis was performed on 14,267 2D mammograms collected from women aged 48-55 years who underwent BC screening within three studies: RETomo, Florence study and PROCAS. BD was expressed through clinical Breast Imaging Reporting and Data System (BI-RADS) density classification. Women in BI-RADS D category had a 2.6 (95% CI 1.5-4.4) and a 3.6 (95% CI 1.4-9.3) times higher risk of incident and interval cancer, respectively, than women in the two lowest BD categories. The ability of DSM to predict risk of incident cancer was non-inferior to radiologists' visual assessment as both point estimate and lower bound of 95% CI (AUC 0.589; 95% CI 0.580-0.597) were above the predefined visual assessment threshold (AUC 0.571). AUC for interval (AUC 0.631; 95% CI 0.623-0.639) cancers was even higher. BD assessed with new fully automated method is positively associated with BC risk and is not inferior to radiologists' visual assessment. It is an even stronger marker of interval cancer, confirming an appreciable masking effect of BD that reduces mammography sensitivity.
Sponsorship
European Union's Horizon 2020 research and innovation programme. (755394)
European Union’s Horizon 2020 research and innovation programme. (755394)
Identifiers
PMC8494838, 34615978
External DOI: https://doi.org/10.1038/s41598-021-99433-3
This record's URL: https://www.repository.cam.ac.uk/handle/1810/330416
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk